Susanne Kaspar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Susanne Kaspar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Pache
Department for Occupational and Environmental Health, Unisanté, University Center for Primary Care and Public Health & University of Lausanne, Lausanne, Switzerland
2 shared publications - Myriam Borgatta
Unisanté, University Center for Primary Care and Public Health & University of Lausanne, Lausanne, Switzerland
2 shared publications - Nancy Brenna Hopf
Unisante, University Center for Primary Care and Public Health & University of Lausanne, Switzerland
2 shared publications - Aurélie Berthet
Department of Occupational and Environmental Health, Unisanté, Center for Primary Care and Public Health & University of Lausanne, Lausanne, Switzerland
1 shared publication - Gregory Plateel
Forensic Toxicology and Chemistry Unit, University Centre of Legal Medicine Lausanne-Geneva, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
1 shared publication - Jamal Bouitbir
Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
1 shared publication
Latest Publications
- Open Access
- 10 March 2026
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (6) , 2367-2379
Urinary metabolite elimination from inhaled propylene glycol butyl ether (PGBE) and propylene glycol methyl ether (PGME) in healthy participants
Glycol ethers are amphiphilic organic solvents, found as mixtures of α- (secondary alcohol) and β- (primary alcohol) isomers. Propylene glycol ethers (PGE) and ethylene glycol ethers (EGE) are the most common derivatives of the glycol ethers family. Among the PGE family, propylene glycol monomethyl ether (PGME, CAS # 107-98-2) and propylene glycol monobutyl ether (PGBE, CAS # 5131-66-8) are widely used. Regulations for PGME limit the β-isomer to < 5% due to its metabolism to alkoxy propionic acid, which has been associated reproductive and neurotoxic effects similar to those observed with ethylene glycol ethers. Other PGEs do not have such restrictions despite similar isomeric composition. Propylene glycol ethers are used in many commercial products, including cleaning products, and enter the body rapidly via lungs, skin, and ingestion. We hypothesized that PGBE is metabolized to 2-butoxypropionic acid (2-BPA), as suggested by in vitro hepatocyte experiments, and that 2-BPA would be quantifiable in urine from healthy participants (N = 17) following a 2-h exposure to a vapor mixture containing 15 ppm PGBE and 35 ppm PGME. Metabolites were quantified with liquid chromatography with quadrupole mass spectrometry (LC-MS/MS). Our in vitro hepatocyte experiments showed that PGBE was metabolized to 2-BPA. Urinary metabolite concentrations from the participants were greater for PGBE compared to PGME, and their peak elimination occurred at 1 h post exposure. Our findings show that β-isomers in commercial propylene glycol ethers can readily metabolize to the corresponding alkoxy propionic acid. However, current toxicological hazard assessments are insufficient to evaluate possible health implications.
- 10 March 2026
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (6) , 2367-2379
Open AccessUrinary metabolite elimination from inhaled propylene glycol butyl ether (PGBE) and propylene glycol methyl ether (PGME) in healthy participants
Glycol ethers are amphiphilic organic solvents, found as mixtures of α- (secondary alcohol) and β- (primary alcohol) isomers. Propylene glycol ethers (PGE) and ethylene glycol ethers (EGE) are the most common derivatives of the glycol ethers family. Among the PGE family, propylene glycol monomethyl ether (PGME, CAS # 107-98-2) and propylene glycol monobutyl ether (PGBE, CAS # 5131-66-8) are widely used. Regulations for PGME limit the β-isomer to < 5% due to its metabolism to alkoxy propionic acid, which has been associated reproductive and neurotoxic effects similar to those observed with ethylene glycol ethers. Other PGEs do not have such restrictions despite similar isomeric composition. Propylene glycol ethers are used in many commercial products, including cleaning products, and enter the body rapidly via lungs, skin, and ingestion. We hypothesized that PGBE is metabolized to 2-butoxypropionic acid (2-BPA), as suggested by in vitro hepatocyte experiments, and that 2-BPA would be quantifiable in urine from healthy participants (N = 17) following a 2-h exposure to a vapor mixture containing 15 ppm PGBE and 35 ppm PGME. Metabolites were quantified with liquid chromatography with quadrupole mass spectrometry (LC-MS/MS). Our in vitro hepatocyte experiments showed that PGBE was metabolized to 2-BPA. Urinary metabolite concentrations from the participants were greater for PGBE compared to PGME, and their peak elimination occurred at 1 h post exposure. Our findings show that β-isomers in commercial propylene glycol ethers can readily metabolize to the corresponding alkoxy propionic acid. However, current toxicological hazard assessments are insufficient to evaluate possible health implications.
- Open Access
- 12 November 2025
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 271, 114706
Urinary excretion of propylene glycol butyl ether (PGBE) and propylene glycol methyl ether (PGME) in healthy human participants and workers
- 12 November 2025
- Published by Elsevier in International Journal of Hygiene and Environmental Health
- Vol. 271, 114706
Open AccessUrinary excretion of propylene glycol butyl ether (PGBE) and propylene glycol methyl ether (PGME) in healthy human participants and workers